Anna Andoni, Shayann Ramedani, Benjamin I Rosner, Aenor Sawyer
{"title":"NODE.健康会议报告和小组讨论--COVID-19 期间美国食品药品管理局对数字健康技术和数字健康创新不断变化的监管格局:与 Eric Topol 和 Bakul Patel 的讨论,由 Aenor Sawyer 主持。","authors":"Anna Andoni, Shayann Ramedani, Benjamin I Rosner, Aenor Sawyer","doi":"10.1159/000512681","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11242,"journal":{"name":"Digital Biomarkers","volume":"4 3","pages":"128-133"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772872/pdf/","citationCount":"0","resultStr":"{\"title\":\"NODE. Health Meeting Report and Panel Discussion - The FDA's Changing Regulatory Landscape for Digital Health Technologies and Digital Health Innovation during COVID-19: A Discussion with Eric Topol and Bakul Patel, Moderated by Aenor Sawyer.\",\"authors\":\"Anna Andoni, Shayann Ramedani, Benjamin I Rosner, Aenor Sawyer\",\"doi\":\"10.1159/000512681\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11242,\"journal\":{\"name\":\"Digital Biomarkers\",\"volume\":\"4 3\",\"pages\":\"128-133\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-12-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772872/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Digital Biomarkers\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000512681\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/9/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"Computer Science\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digital Biomarkers","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000512681","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/9/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Computer Science","Score":null,"Total":0}
NODE. Health Meeting Report and Panel Discussion - The FDA's Changing Regulatory Landscape for Digital Health Technologies and Digital Health Innovation during COVID-19: A Discussion with Eric Topol and Bakul Patel, Moderated by Aenor Sawyer.